Literature DB >> 15696970

Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas.

Kyoko Komatsu1, Yoko Nakanishi, Norimichi Nemoto, Tomokatsu Hori, Tatsuo Sawada, Makio Kobayashi.   

Abstract

The matrix metalloproteinase (MMP) family members catalyze extracellular proteolysis. Recent reports have suggested that expression of MMP-2 and -9 might play a critical role in neoplastic tissue invasion or metastasis. In this study, the relationship between the expression of MMP-2 and -9 and the histological features of tissues from 21 cases of human glioma were investigated. MMP-2 and -9 proteins were detected by immnohistochemical studies. Amplification of MMP-2 and -9 mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR) assay. MMP-2 and -9 mRNA was measured quantitatively by the real-time RT-PCR method. Immunohistochemically, 38% of the cases were positive for MMP-2. Amplification of MMP-2 mRNA by RT-PCR was detected in 62% of the cases. There was no significant relationship between the expression of MMP-2 protein or mRNA and the biological nature of the tumors, including aggressiveness and histologic classification. The quantity of MMP-2 mRNA was 0.035 +/- 0.113 (MMP-2/GAPDH %), which was significantly elevated in cases of neoplastic dissemination or recurrence (P < 0.05). Tumor cells were immunohistochemically positive for MMP-9 in 81% of the samples. A positive reaction was found not only in neoplastic cells but also in endothelial cells, suggesting that the expression of MMP-9 protein might be associated with tumoral angiogenesis. The expression of mRNA in MMP-9 was detected in 91% of the cases, suggesting a close relationship between expression of MMP-9 and malignancy. The quantity of MMP-9 was 0.097 +/- 0.113 (MMP-9/GAPDH %) in all samples, which was significantly elevated in cases of glioblastoma (P < 0.05). The average Ki-67 labeling index was 8.14 +/- 5.26 in samples from G2 glioma, 19.92 +/- 11.29 in samples from G3 glioma, and 23.52 +/- 10.14 in samples from glioblastoma. All of the cases with elevated indices had recurrence or dissemination. The results of our study suggest that quantity analyses of MMP-2 and -9 mRNA and Ki-67 labeling index should be useful for discerning tumoral behaviors such as invasion, dissemination, and recurrence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15696970     DOI: 10.1007/bf02482184

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  24 in total

1.  Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.

Authors:  Elisa Nuti; Francesca Casalini; Salvatore Santamaria; Pamela Gabelloni; Sara Bendinelli; Eleonora Da Pozzo; Barbara Costa; Luciana Marinelli; Valeria La Pietra; Ettore Novellino; M Margarida Bernardo; Rafael Fridman; Federico Da Settimo; Claudia Martini; Armando Rossello
Journal:  Eur J Med Chem       Date:  2011-04-02       Impact factor: 6.514

2.  Freiburg neuropathology case conference: widespread mass lesions after resection of a glioblastoma multiforme.

Authors:  C A Taschner; S Brendecke; A Weyerbrock; K Egger; M Prinz
Journal:  Clin Neuroradiol       Date:  2012-11-07       Impact factor: 3.649

3.  Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.

Authors:  Qi Wang; Jun Qian; Junyu Wang; Chun Luo; Juxiang Chen; Guohan Hu; Yicheng Lu
Journal:  J Neurooncol       Date:  2013-01-06       Impact factor: 4.130

4.  Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.

Authors:  Fabio M Iwamoto; Andreas F Hottinger; Sasan Karimi; Elyn Riedel; Jocelynn Dantis; Maryam Jahdi; Katherine S Panageas; Andrew B Lassman; Lauren E Abrey; Martin Fleisher; Lisa M Deangelis; Eric C Holland; Adília Hormigo
Journal:  J Neurooncol       Date:  2011-06-28       Impact factor: 4.130

5.  Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺ extrusion, cell migration and survival.

Authors:  Damin Cong; Wen Zhu; Yejie Shi; Kelli B Pointer; Paul A Clark; Hongmei Shen; John S Kuo; Shaoshan Hu; Dandan Sun
Journal:  Carcinogenesis       Date:  2014-04-09       Impact factor: 4.944

6.  Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

Authors:  Heesang Song; Yonghe Li; Jiyeon Lee; Alan L Schwartz; Guojun Bu
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

7.  Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens.

Authors:  Sergio Comincini; Mayra Paolillo; Giulia Barbieri; Silvia Palumbo; Elena Sbalchiero; Alberto Azzalin; Marika A Russo; Sergio Schinelli
Journal:  J Biomed Biotechnol       Date:  2009-07-30

8.  In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines.

Authors:  Hani J Marcus; Keri L H Carpenter; Stephen J Price; Peter J Hutchinson
Journal:  J Neurooncol       Date:  2009-08-28       Impact factor: 4.130

9.  Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.

Authors:  Tanwarat Sanvoranart; Aungkura Supokawej; Pakpoom Kheolamai; Yaowalak U-Pratya; Niphon Poungvarin; Sith Sathornsumetee; Surapol Issaragrisil
Journal:  Tumour Biol       Date:  2016-09-20

10.  Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas.

Authors:  Nunung Nur Rahmah; Keiichi Sakai; Jun Nakayama; Kazuhiro Hongo
Journal:  Neurosurg Rev       Date:  2009-10-28       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.